Role of the Fast Kinetics of Pyroglutamate-Modified Amyloid-β Oligomers in Membrane Binding and Membrane Permeability

[Image: see text] Membrane permeability to ions and small molecules is believed to be a critical step in the pathology of Alzheimer’s disease (AD). Interactions of oligomers formed by amyloid-β (Aβ) peptides with the plasma cell membrane are believed to play a fundamental role in the processes leading to membrane permeability. Among the family of Aβs, pyroglutamate (pE)-modified Aβ peptides constitute the most abundant oligomeric species in the brains of AD patients. Although membrane permeability mechanisms have been studied for full-length Aβ(1–40/42) peptides, these have not been sufficiently characterized for the more abundant Aβ(pE3–42) fragment. Here we have compared the adsorbed and membrane-inserted oligomeric species of Aβ(pE3–42) and Aβ(1–42) peptides. We find lower concentrations and larger dimensions for both species of membrane-associated Aβ(pE3–42) oligomers. The larger dimensions are attributed to the faster self-assembly kinetics of Aβ(pE3–42), and the lower concentrations are attributed to weaker interactions with zwitterionic lipid headgroups. While adsorbed oligomers produced little or no significant membrane structural damage, increased membrane permeabilization to ionic species is understood in terms of enlarged membrane-inserted oligomers. Membrane-inserted Aβ(pE3–42) oligomers were also found to modify the mechanical properties of the membrane. Taken together, our results suggest that membrane-inserted oligomers are the primary species responsible for membrane permeability.